- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
DNAnexus Cloud Genomics Platform Now Supports Data Management and Genomic Analysis for Leading Genome Research Center
MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–DNAnexus Inc., the global leader in genome informatics and data management, today announced that the Stanford Center for Genomics and Personalized Medicine (SCGPM) has adopted the company’s cloud genomics platform to support data analysis and sharing for its sequencing facility. Researchers across nearly 80 laboratories now have access to SCGPM’s DNAnexus portal …
MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–DNAnexus
Inc., the global leader in genome informatics and data management,
today announced that the Stanford Center for Genomics and Personalized
Medicine (SCGPM)
has adopted the company’s cloud genomics platform to support data
analysis and sharing for its sequencing facility. Researchers across
nearly 80 laboratories now have access to SCGPM’s DNAnexus portal for
the delivery and analysis of their genomic sequencing data.
The SCGPM seeks to advance genomic technology so that genetic and
molecular profiling will become powerful tools routinely used to
understand, detect, prevent, and treat complex disease. To move toward
this goal, a centralized command center was needed to securely store,
share, and analyze the large volumes of genomic data that are generated
by the core sequencing facility. DNAnexus provided a scalable enterprise
solution to automate, manage, and deliver samples generated by the core
sequencing facility to their laboratory customers. At its initial
launch, 40-50 sequencing lanes were delivered per week through the new
DNAnexus portal, a throughput rate which can scale up quickly as
sequencing volume increases.
“Stanford has long been a leader in genomics and continues to develop
new approaches to revolutionize the way medicine is practiced. Their
sequencing services require the management of a tremendous amount of
sensitive data across a distributed network of researchers and
scientists. This is a massive undertaking that requires a secure and
proven genome informatics and data management platform,” said Richard
Daly, CEO of DNAnexus. “DNAnexus is proud to support SCGPM’s sequencing
services and the broad research initiatives of its laboratory customers.”
About DNAnexus
DNAnexus combines expertise in cloud computing and bioinformatics to
create the global network for genomics, operating in North America,
Europe, Asia-Pacific (including China), South America, and Africa. The
secure, scalable, and collaborative cloud-based DNAnexus
Platform helps thousands of researchers across a spectrum of
industries – biopharmaceutical, bioagricultural, sequencing services,
clinical diagnostics, government, and research consortia – accelerate
their genomics programs globally. For more information on DNAnexus,
please visit www.dnanexus.com
or follow the company @DNAnexus.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.